AB1 in Adult Patients with Sickle Cell Disease (SCD)
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Nirmish Shah
- Target Recruit Count
- 16
- Registration Number
- NCT05261711
- Locations
- 🇺🇸
East Carolina University, Greenville, North Carolina, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
🇺🇸Augusta University Medical Center, Augusta, Georgia, United States
Apixaban in Patients With Sickle Cell Disease
Phase 3
Terminated
- Conditions
- Sickle Cell DiseaseVaso-occlusive CrisisReduction in Hospitalizations
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-07-01
- Last Posted Date
- 2020-03-11
- Lead Sponsor
- Nirmish Shah
- Target Recruit Count
- 16
- Registration Number
- NCT02179177
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath